Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Palyutin, I. Zilber, A. Petrochenko (Yaroslavl, Russian Federation). The analysis anti-asthma drugs consumption dynamics in Yaroslavl. Eur Respir J 2012; 40: Suppl. 56, 1007

Member's Comments

No comment yet.

Related content which might interest you: Changes in the use of anti-asthmatic medication in an international cohort Source: Eur Respir J 2005; 26: 1047-1055 Year: 2005 Cannabis use is associated with reduced harm perception towards illicit drugs and experimentation with new psychoactive substances among European adolescents and young adults Source: International Congress 2015 – Epidemiology, public health and economics of tobacco Year: 2015 Evaluation of the utilization patterns of anti-asthma medications at a university hospital Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 Availability of anti-tuberculosis drugs in Europe Source: Eur Respir J 2012; 40: 500-503 Year: 2012 Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey Source: Eur Respir J 2015; 45: 1081-1088 Year: 2015 What are kids experimenting with? Epidemiology and trends of tobacco use and mental effects of nicotine and cannabis use Source: Virtual Congress 2021 – Orphan childhood disease: nicotine and cannabis addiction Year: 2021 Use of anti-inflammatory therapy for asthma in a tropical setting Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003 Regional differences in the prescription of antiasthmatic drugs in the Federal Republic of Germany Source: Eur Respir J 2001; 18: Suppl. 33, 442s Year: 2001 Prescription rates for various classes of COPD & asthma medication in Turkey Source: Eur Respir J 2001; 18: Suppl. 33, 425s Year: 2001 Safety signals concerning asthma drugs in children Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma Year: 2017 Unlicensed and off-label prescription of respiratory drugs to children Source: Eur Respir J 2004; 23: 310-313 Year: 2004 Time to ban short-acting ß-agonists and use anti-inflammatory treatment as required to improve outcomes Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021 The effect of active and passive smoking on inhaled drugs in respiratory patients Source: Eur Respir Mon; 2008: 42: 100–105 Year: 2008 Effectiveness of a phytochemical drug based on hypericum in a smoking cessation program directed to recalcitrant smokers Source: Eur Respir J 2005; 26: Suppl. 49, 388s Year: 2005 Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Occupational exposure and incidence of asthma based on prescription of drugs. Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways Year: 2018 The comparative analysis of treatment effectiveness in children and adolescents with MDR TB with anti-TB drugs of the first and second lines Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 Tobacco smoke and inhaled medications interactions (TIMED) study: asthma and COPD smokers’ habits about inhalers and cigarettes. Preliminary results Source: Annual Congress 2004 - Update on smoking related damage and cessation Year: 2004